Latest biopharmaceutical Stories
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it had
Led by CSL Behring performance, the company focuses on sustainable business practices, strong results to provide patients with lifesaving, life-enhancing therapies around the world. KING OF
Breadth and depth of leadership and commercial manufacturing experience a strong fit for company's growth and culture SEATTLE, Dec.
- 24 UCB-sponsored presentations including new data on VIMPAT® (lacosamide) BRUSSELS, Dec.
FREMONT, Calif., Dec. 1, 2014 /PRNewswire/ -- Ardelyx, Inc.
DALLAS and NEW YORK, Nov. 24, 2014 /PRNewswire/ -- PlasmaTech Biopharmaceuticals, Inc. announced today that FINRA has approved a change of Company's stock ticker symbol.
BOULDER, Colo., Nov. 19, 2014 /PRNewswire/ -- N30 Pharmaceuticals, Inc.
- A volcanic mudflow.